Bharat in BetaEveryONE Medicines
Source
- Khosla Ventures, selected explicit portfolio theses (opens in a new tab)EveryONE MedicinesPage updated: 1 Sep 2026
Source example
EveryONE Medicines develops individually tailored genetic treatments.
Related entries
No. 278Venture thesisHealth and wellbeingState-of-the-art computing models and proprietary data generation are opening up new frontiers for TechBio companies.
Biological uncertainty and slow experimental feedback make drug discovery expensive and difficult to predict. The report discusses Link proprietary biological measurements, computational hypotheses and repeated wet-lab tests; Build single-cell disease atlases and tumor spatial models; Monetize through research partnerships, model access or an internally developed drug pipeline. Examples cited: Recursion, Relation, Noetik.
No. 280Venture thesisHealth and wellbeingNew imaging, AI, and manufacturing tools are finally making the microbiome druggable.
Microbial communities are hard to observe, causally interpret and manufacture consistently as therapeutic products. The report discusses Spatial labeling, imaging and machine learning to map host-microbe interactions; Anaerobic manufacturing of defined live microbial mixtures; Investigational programs for cancer-treatment response, treatment-associated colitis and environmental enteric dysfunction. Examples cited: Kanvas Biosciences.
No. 284Existing businessHealth and wellbeingMonitoring industrial machine health
Augury targets equipment inefficiency and unexpected downtime.